Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir

Published:1997-10 Issue:12 Volume:11 Page:F95-F99
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Lorenzi Patrizio,Yerly Sabine,Abderrakim Karmine,Fathi Marc,Rutschmann Olivier T.,von Overbeck Jan,Leduc Dominique,Perrin Luc,Hirschel Bernard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference11 articles.

1. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

2. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

3. The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics

4. In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects

5. Solid-phase extraction for the screening of acidic, neutral and basic drugs in plasma using a single-column procedure on Bond Elut Certify

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses;Viruses;2022-11-30

2. Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure;Scientific Reports;2020-02-05

3. Ritonavir-Induced Suicidal Death of Human Erythrocytes;Basic & Clinical Pharmacology & Toxicology;2016-01-20

4. Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy;HIV/AIDS - Research and Palliative Care;2015-12

5. Don't Get Boxed In: Commentary on the Visual Inspection Practices to Assess Exposure-Response Relationships From Binary Clinical Variables;The Journal of Clinical Pharmacology;2012-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3